Nina Feldman

The Philadelphia Association of Black Journalists hosted a workshop for journalists on covering cannabis in a new legal, cultural and economic landscape.

In a decision that could pave the way for the 1st U.S. supervised injection site, a judge ruled Safehouse’s plan wouldn’t violate the Controlled Substances Act.

The workers’ top priority is adding successorship language to a contract. That would require any new owner to honor the union accord already in place.

Philly says the ban, started in January at city-funded centers, has been a success. But providers and clients say it’s still easy to smoke in treatment.

STC Opco — a partnership between Reading-based Tower Health and Drexel University — bought the North Philadelphia facility for $50 million.

Sale of the North Philadelphia hospital is part of the Chapter 11 bankruptcy proceeding involving Philadelphia Academic Health, which also owns Hahnemann.

Moderate candidates tried to sway Philadelphia workers away from public health care, arguing it would strip them of their hard earned benefits.

A federal judge has temporarily stopped the sale of more than 550 slots for doctors in training, cutting off a potential infusion of funds to the troubled hospital.

The federal Centers for Medicare and Medicaid Services, which funds the residencies, opposed the sale of the 550-plus slots from the beginning.

The nonprofit faced off Thurs. against federal prosecutors on whether a Philly supervised injection site will violate the Controlled Substances Act.

The residency slots sold for $55 million at auction as part of Chapter 11 proceedings, pending the judge’s approval. He says he’ll rule Thursday afternoon.

Hahnemann University Hospital is back in federal bankruptcy court Weds. where a judge will rule on whether the sale of its residency programs can go ahead.